TOG Review (RCOG Journal)
MRCOG Part 2
Maternal Medicine
Lichen sclerosus for the obstetrician
Key Statistics
- ≤3% — Population prevalence of vulval LS
- 5%→<1% — Lifetime vulval cancer risk, untreated vs TCS-treated
- 60% — Reported symptom worsening post-partum (survey, n=206 pregnancies)
Don't-miss facts
-
TCS is safe throughout pregnancy and post-partum/lactation – no association with congenital abnormality, preterm birth, low Apgar, or fetal death
-
Avoid calcineurin inhibitors and oral retinoids in pregnancy; stop topical retinoids 1 month before conception
-
Mode of birth per standard obstetric indications – LS alone rarely mandates Caesarean; vaginal birth usually fine if well controlled, no significant introital stenosis
-
Only 12% of women with LS report an affected first-degree relative – no genetic/blood diagnostic test available
-
Compliance with TCS drops post-partum (69%→76%→60% in one series) → increase surveillance/follow-up post-partum
-
60% report symptom worsening post-partum (survey, n=206 pregnancies), worsening progressively over first 12 months
-
Low-dose vaginal oestradiol (≤10 mcg) not detected in breast milk in available studies – safe adjunct for post-partum atrophic symptoms regardless of lactation status
-
Lifetime vulval cancer risk with poorly controlled LS ~5%, falls to <1% with adequate TCS treatment/monitoring
Pregnancy TCS options
Continue: clobetasol 0.05% or mometasone 0.1%, once–twice weekly maintenance Avoid: calcineurin inhibitors, oral retinoids
Abbreviation Key
- LS — lichen sclerosus
- GSM — genitourinary syndrome of menopause
- TCS — topical corticosteroid
- GSL — genitourinary syndrome of lactation
- HLA — human leukocyte antigen
- PFPT — pelvic floor physiotherapy
- miRNA — micro RNA
- OASI — obstetric anal sphincter injury
- VVA — vulvovaginal atrophy
- Euroguiderm — European Dermatology Forum guideline body
Source: Lewis FM, Lev-Sagie A, Krapf J. Lichen sclerosus for the obstetrician: a review of comprehensive care for pregnancy, parturition, post-partum and breastfeeding. The Obstetrician & Gynaecologist 2026;28:93–99. doi:10.1111/tog.70032
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).